Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.

International audience

Data and Resources

Additional Info

Field Value
Source ISSN: 0007-1048
Author Natarajan-Amé, Shanti, Park, Sophie, Ades, Lionel, Vey, Norbert, Guerci-Bresler, Agnès, Cahn, Jean-Yves, Etienne, Gabriel, Bordessoule, Dominique, Ravoet, Christophe, Legros, Laurence, Cheze, Stephane, Stamatoullas, Aspasia, Berger, Elisabeth, Schmidt, Aline, Charbonnier, Aude, Chaury, Marie-Pierre, Braun, Thorsten, Fenaux, Pierre, Dreyfus, Francois, Renseigné, Non
Maintainer CCSD
Last Updated May 15, 2026, 12:31 (UTC)
Created May 15, 2026, 12:31 (UTC)
Identifier hal-00771197
Language en
contributor Service d'hématologie clinique [Avicenne] ; Université Paris 13 (UP13)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Avicenne [AP-HP] ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
creator Natarajan-Amé, Shanti
date 2012-07-15T00:00:00
harvest_object_id 6f0bf420-2bd5-426d-a514-f26bf13d0d5a
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2026-04-01T00:00:00
relation info:eu-repo/semantics/altIdentifier/doi/10.1111/j.1365-2141.2012.09153.x
set_spec type:ART